SU921467A3 - Способ получени производных морфина - Google Patents

Способ получени производных морфина Download PDF

Info

Publication number: SU921467A3
Authority: SU; USSR - Soviet Union
Prior art keywords: carbon atoms; alkyl; hydrogen atom; general formula; cycloalkyl
Prior art date: 1977-03-23

Application number

SU782595556A

Other languages

English (en)

Russian (ru)

Inventor

Юрек Кобылески Рышард

Джоффри Гест Ян

Вильям Льюис Джон

Вильям Кирби Гордон

Original Assignee

Рекитт Энд Колман Продактс Лимитед (Фирма)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-03-23

Filing date

1978-03-21

Publication date

1982-04-15

1978-03-21 Application filed by Рекитт Энд Колман Продактс Лимитед (Фирма) filed Critical Рекитт Энд Колман Продактс Лимитед (Фирма)

1982-04-15 Application granted granted Critical

1982-04-15 Publication of SU921467A3 publication Critical patent/SU921467A3/ru

Links

BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical class O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title claims abstract description 9
238000000034 method Methods 0.000 title claims description 9
150000001875 compounds Chemical class 0.000 claims abstract description 15
125000004432 carbon atom Chemical group C* 0.000 claims description 25
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
125000000217 alkyl group Chemical group 0.000 claims description 13
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims description 8
125000003710 aryl alkyl group Chemical group 0.000 claims description 6
125000000753 cycloalkyl group Chemical group 0.000 claims description 6
125000003342 alkenyl group Chemical group 0.000 claims description 5
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
239000001301 oxygen Substances 0.000 claims description 4
229910052760 oxygen Inorganic materials 0.000 claims description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 4
150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 3
125000003118 aryl group Chemical group 0.000 claims description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
229960005181 morphine Drugs 0.000 claims description 3
239000000460 chlorine Substances 0.000 claims description 2
229910052801 chlorine Inorganic materials 0.000 claims description 2
125000001309 chloro group Chemical group Cl* 0.000 claims description 2
125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
239000003814 drug Substances 0.000 claims description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
229910052757 nitrogen Inorganic materials 0.000 claims description 2
125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
125000004429 atom Chemical group 0.000 claims 1
229910052799 carbon Inorganic materials 0.000 claims 1
229940079593 drug Drugs 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
229940126601 medicinal product Drugs 0.000 claims 1
230000000694 effects Effects 0.000 abstract description 3
150000003839 salts Chemical class 0.000 abstract 2
210000003169 central nervous system Anatomy 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
239000013078 crystal Substances 0.000 description 4
239000003208 petroleum Substances 0.000 description 4
238000001953 recrystallisation Methods 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000000556 agonist Substances 0.000 description 3
239000000284 extract Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000003533 narcotic effect Effects 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
230000003042 antagnostic effect Effects 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
ZENNIHDHUIWZRA-SEJAZBPASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC ZENNIHDHUIWZRA-SEJAZBPASA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
LKBREHQHCVRNFR-UHFFFAOYSA-K [B+3].[Br-].[Br-].[Br-] Chemical compound [B+3].[Br-].[Br-].[Br-] LKBREHQHCVRNFR-UHFFFAOYSA-K 0.000 description 1
IUHFWCGCSVTMPG-UHFFFAOYSA-N [C].[C] Chemical group [C].[C] IUHFWCGCSVTMPG-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000001270 agonistic effect Effects 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
150000003797 alkaloid derivatives Chemical class 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000020335 dealkylation Effects 0.000 description 1
238000006900 dealkylation reaction Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
239000003480 eluent Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
239000002085 irritant Substances 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
239000000463 material Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
229910001948 sodium oxide Inorganic materials 0.000 description 1
239000002904 solvent Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SU782595556A 1977-03-23 1978-03-21 Способ получени производных морфина SU921467A3 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB12325/77A GB1593191A (en)	1977-03-23	1977-03-23	Derivatives of morphine

Publications (1)

Publication Number	Publication Date
SU921467A3 true SU921467A3 (ru)	1982-04-15

Family

ID=10002423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SU782595556A SU921467A3 (ru)	1977-03-23	1978-03-21	Способ получени производных морфина

Country Status (24)

Country	Link
US (1)	US4241066A (2)
JP (1)	JPS53119899A (2)
AT (1)	AT361139B (2)
AU (1)	AU519643B2 (2)
BE (1)	BE865183A (2)
CA (1)	CA1089456A (2)
CH (1)	CH629809A5 (2)
CS (1)	CS200542B2 (2)
DD (1)	DD133950A5 (2)
DE (1)	DE2812580A1 (2)
DK (1)	DK149858C (2)
ES (1)	ES468173A1 (2)
FI (1)	FI68236C (2)
FR (1)	FR2384774A1 (2)
GB (1)	GB1593191A (2)
IE (1)	IE46443B1 (2)
IT (1)	IT1105176B (2)
LU (1)	LU79294A1 (2)
NL (1)	NL7803083A (2)
NZ (1)	NZ186692A (2)
PL (1)	PL114723B1 (2)
SE (1)	SE436131B (2)
SU (1)	SU921467A3 (2)
ZA (1)	ZA781527B (2)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4362870A (en) *	1980-01-16	1982-12-07	Regents Of The University Of Minnesota	Selective opioid receptor alkylating agents
US4401672A (en) *	1981-10-13	1983-08-30	Regents Of The University Of Minnesota	Non-addictive narcotic antitussive preparation
EP0103636B1 (en) *	1982-03-16	1990-09-12	Rockefeller University	Use of opium antagonists for the manufacture of medicaments for controlling gastrointestinal dysmotility
GB8711558D0 (en) *	1987-05-15	1987-06-17	Reckitt & Colmann Prod Ltd	Derivative of codeine
KR970011390B1 (ko) *	1992-01-23	1997-07-10	도레이 가부시키가이샤	모르피난 유도체와 약리학적으로 허용되는 이의 산 부가염 및 이를 함유하는 약제학적 조성물
IT1269826B (it) *	1994-05-24	1997-04-15	Paolo Minoia	Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
HRP20150037T4 (hr)	2003-04-08	2022-09-02	Progenics Pharmaceuticals, Inc.	Farmaceutske formulacije koje sadrže metilnaltrekson
US20060063792A1 (en) *	2004-09-17	2006-03-23	Adolor Corporation	Substituted morphinans and methods of their use
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es)	2005-05-25	2007-11-28	Progenics Pharm Inc	Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
ES2357216T3 (es)	2005-06-16	2011-04-20	Mallinckrodt, Inc.	Una ruta de síntesis de 14-hidroxil-opiáceos a través de 1-halo-tebaína o análogos.
KR101421747B1 (ko) *	2006-04-21	2014-07-30	넥타르 테라퓨틱스	모르피논의 입체선택적 환원
TWI489984B (zh)	2006-08-04	2015-07-01	Wyeth Corp	用於非經腸道傳輸化合物之配方及其用途
MX2009010550A (es)	2007-03-29	2009-12-14	Progenics Pharm Inc	Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
SI2565195T1 (sl)	2007-03-29	2015-09-30	Wyeth Llc	Periferalni opioidni receptorji in antagonisti in njih uporaba
CL2008000905A1 (es)	2007-03-29	2008-08-22	Progenics Pharm Inc	Compuestos derivados de morfina, antagonistas del receptor opioide periferico; metodo de preparacion; composicion farmaceutica; y uso para reducir los efectos de la actividad opioide endogena.
EP2240489A1 (en)	2008-02-06	2010-10-20	Progenics Pharmaceuticals, Inc.	Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
CA2676881C (en)	2008-09-30	2017-04-25	Wyeth	Peripheral opioid receptor antagonists and uses thereof
CA2738761C (en)	2008-09-30	2019-10-29	Mallinckrodt Inc.	Processes for the production of buprenorphine with reduced impurity formation
CA2738758C (en)	2008-09-30	2016-11-29	Mallinckrodt Inc.	Processes for the alkylation of norbuprenorphine with reduced impurity formation
WO2015082932A1 (en)	2013-12-05	2015-06-11	The University Of Bath	Novel opioid compounds and their uses
CN110330500B (zh) *	2019-07-12	2021-11-23	宜昌人福药业有限责任公司	一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3322771A (en) *		1967-05-30		Intermediates for preparing thebaine derivatives
US3332950A (en) *	1963-03-23	1967-07-25	Endo Lab	14-hydroxydihydronormorphinone derivatives
IL26896A (en) *	1966-01-19	1970-11-30	Endo Lab	14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
BE788478A (fr) *	1971-09-08	1973-03-06	Bristol Myers Co	Procede de preparation de composes analgesiques
US4017497A (en) *	1975-11-18	1977-04-12	Bristol-Myers Company	Process for the preparation of 14-hydroxymorphinan derivatives
US4089855A (en) *	1976-04-23	1978-05-16	Cornell Research Foundation, Inc.	Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby

1977
- 1977-03-23 GB GB12325/77A patent/GB1593191A/en not_active Expired
1978
- 1978-03-14 IE IE515/78A patent/IE46443B1/en unknown
- 1978-03-14 NZ NZ186692A patent/NZ186692A/xx unknown
- 1978-03-15 ZA ZA00781527A patent/ZA781527B/xx unknown
- 1978-03-15 US US05/886,833 patent/US4241066A/en not_active Expired - Lifetime
- 1978-03-21 FI FI780882A patent/FI68236C/fi not_active IP Right Cessation
- 1978-03-21 AU AU34357/78A patent/AU519643B2/en not_active Expired
- 1978-03-21 SU SU782595556A patent/SU921467A3/ru active
- 1978-03-22 AT AT204278A patent/AT361139B/de not_active IP Right Cessation
- 1978-03-22 ES ES468173A patent/ES468173A1/es not_active Expired
- 1978-03-22 DE DE19782812580 patent/DE2812580A1/de not_active Ceased
- 1978-03-22 JP JP3354678A patent/JPS53119899A/ja active Granted
- 1978-03-22 SE SE7803328A patent/SE436131B/sv not_active IP Right Cessation
- 1978-03-22 BE BE186174A patent/BE865183A/xx not_active IP Right Cessation
- 1978-03-22 NL NL7803083A patent/NL7803083A/xx not_active Application Discontinuation
- 1978-03-22 CA CA299,532A patent/CA1089456A/en not_active Expired
- 1978-03-22 CS CS781846A patent/CS200542B2/cs unknown
- 1978-03-22 DK DK130078A patent/DK149858C/da not_active IP Right Cessation
- 1978-03-22 PL PL1978205498A patent/PL114723B1/pl unknown
- 1978-03-22 CH CH316078A patent/CH629809A5/fr not_active IP Right Cessation
- 1978-03-22 FR FR7808404A patent/FR2384774A1/fr active Granted
- 1978-03-22 LU LU79294A patent/LU79294A1/xx unknown
- 1978-03-22 IT IT48544/78A patent/IT1105176B/it active
- 1978-03-22 DD DD78204349A patent/DD133950A5/xx unknown

Also Published As

Publication number	Publication date
FI780882A7 (fi)	1978-09-24
FR2384774B1 (2)	1981-10-16
FR2384774A1 (fr)	1978-10-20
CH629809A5 (fr)	1982-05-14
SE436131B (sv)	1984-11-12
IE46443B1 (en)	1983-06-15
AU519643B2 (en)	1981-12-17
GB1593191A (en)	1981-07-15
CS200542B2 (en)	1980-09-15
DK149858C (da)	1987-06-29
ATA204278A (de)	1980-07-15
IE780515L (en)	1978-09-23
ES468173A1 (es)	1979-09-16
AU3435778A (en)	1979-09-27
AT361139B (de)	1981-02-25
BE865183A (fr)	1978-09-22
CA1089456A (en)	1980-11-11
US4241066A (en)	1980-12-23
LU79294A1 (fr)	1979-10-29
PL114723B1 (en)	1981-02-28
IT7848544A0 (it)	1978-03-22
DD133950A5 (de)	1979-01-31
ZA781527B (en)	1979-04-25
DE2812580A1 (de)	1978-10-05
SE7803328L (sv)	1978-09-24
NZ186692A (en)	1980-02-21
NL7803083A (nl)	1978-09-26
FI68236C (fi)	1985-08-12
PL205498A1 (pl)	1979-04-09
FI68236B (fi)	1985-04-30
JPS53119899A (en)	1978-10-19
IT1105176B (it)	1985-10-28
DK130078A (da)	1978-09-24
JPH0112755B2 (2)	1989-03-02
DK149858B (da)	1986-10-13

Publication	Publication Date	Title
SU921467A3 (ru)	1982-04-15	Способ получени производных морфина
JPS61271275A (ja)	1986-12-01	モルヒナン誘導体
DE2062001C2 (de)	1986-10-16	1,2,3,4-Tetrahydro-4-phenylisochinolin-Derivate, deren Säureadditionssalze, Verfahren zu deren Herstellung und pharmazeutisches Präparat
WO1990012574A1 (en)	1990-11-01	Dopamine agonist compounds
Takemoto et al.	1975	Studies on the Constituents of Chloranthus spp. I. The Structures of Two New Amides from Chloranthus serratus and the Isolation of Isofraxidin from C. japonicus
DE2330912B2 (de)	1978-05-18	Verfahren zur Herstellung von Bromergolinverbindungen
Hart et al.	1970	Alkaloids of Alchornea javanensis (Euphorbiaceae): The isolation of hexahydroimidazo [1, 2-a] pyrimidines and guanidines
Schwab	1980	14-(Arylhydroxyamino) codeinones and derivatives as analgetics and antagonists
US3513169A (en)	1970-05-19	5,9-diethyl benzomorphan derivatives
SU867303A3 (ru)	1981-09-23	Способ получени производных тетрагидро-1,3,5-триазин-2,6-диона или их основных солей
NZ195329A (en)	1984-05-31	6,7-benzomorphan derivatives and pharmaceutical compositions
US4198514A (en)	1980-04-15	Lactam compounds
US2959594A (en)	1960-11-08	Iso-benzmorphan derivatives
DE3118521A1 (de)	1982-12-02	Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien
Stevens et al.	1970	Rearrangement reactions of hexose 4-0-sulfonates in the presence of azide and phthalimide nucleophiles
Kaneko et al.	1979	A Novel Synthesis of Revenine and Related Alkaloids by Means of a Photo-rearrangement Reaction of 4-Alkoxy-2-methylquinoline 1-Oxides
EP0202950B1 (en)	1993-09-29	Berban derivatives and their preparation and pharmaceutical formulation
US3859291A (en)	1975-01-07	9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline
EP0101951A1 (en)	1984-03-07	1,3-Dioxolo(4,5-g)quinolines and preparation thereof
US4247697A (en)	1981-01-27	3-Phenoxy morphinans and their derivatives
US3459764A (en)	1969-08-05	Preparation of nitroimidazole carbamates
US3766188A (en)	1973-10-16	Carbonyldioxymorphinan derivatives
US3957785A (en)	1976-05-18	Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
SU1547708A3 (ru)	1990-02-28	Способ получени третбутил производного эрголина
EP0186049B1 (de)	1990-07-04	N-substituierte Aziridin-2-Carbonsäurederivate, Verfahren zu deren Herstellung sowie diese Substanzen enthaltende Arzneimittel